Stanley Hirsch
Directeur/Membre du Conseil chez Rimonyx Pharmaceuticals Ltd.
Postes actifs de Stanley Hirsch
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
Rimonyx Pharmaceuticals Ltd.
 Rimonyx Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Rimonyx Pharmaceuticals Ltd. develops drugs targeted at glycosaminoglycan and protein interactions. It identified a series of novel anti-inflammatory compounds and has recently partnered its lead drug candidate, RX-111, for further preclinical and clinical development. It is focused on developing additional products for a variety of inflammatory and autoimmune indications. The company was founded in 2001 and is headquartered in Ness-Ziona, Israel | Directeur/Membre du Conseil | 25/11/2009 | - |
Historique de carrière de Stanley Hirsch
Statistiques
Internationale
| Israël | 2 |
Opérationnelle
| Director/Board Member | 1 |
Sectorielle
| Health Technology | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Entreprise privées | 1 |
|---|---|
Rimonyx Pharmaceuticals Ltd.
Rimonyx Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Rimonyx Pharmaceuticals Ltd. develops drugs targeted at glycosaminoglycan and protein interactions. It identified a series of novel anti-inflammatory compounds and has recently partnered its lead drug candidate, RX-111, for further preclinical and clinical development. It is focused on developing additional products for a variety of inflammatory and autoimmune indications. The company was founded in 2001 and is headquartered in Ness-Ziona, Israel | Health Technology |
- Bourse
- Insiders
- Stanley Hirsch
- Expérience
